23andMe, the genetic testing giant once valued in the billions, is now navigating Chapter 11 bankruptcy and notifying millions of current and former customers that they may be eligible to file claims as part of the restructuring process. The company and 11 of its subsidiaries, including Lemonaid Health and LPRXOne, filed for bankruptcy protection on […]
Whoop has backed down, somewhat, from the controversial upgrade plans around its Whoop 5.0 fitness tracker. When the company first announced Whoop 5.0 this week, it said members who wanted the new device could either extend their subscriptions by 12 months or pay a one-time upgrade fee of $49 ($79 for the model with EKG
Fitness tracker Whoop faces unhappy customers over upgrade policy Read More »
Billy Evans, partner of Theranos founder Elizabeth Holmes, is working on a new startup that seeks to deliver “human health optimization” through blood testing, according to The New York Times. The Times reportedly spoke to two investors pitched on the startup, called Haemanthus, and also viewed some of Haemanthus’ marketing materials. In those materials, the
Elizabeth Holmes’ partner reportedly fundraising for new blood-testing startup Read More »
At Stripe’s Sessions conference this week, Mark Zuckerberg pitched what he calls the “ultimate business machine”: a fully automated, end-to-end AI ad engine promising to replace agencies, creatives, and media buyers with a single black box. You just need to connect your bank account first. Zuckerberg claims this could be one of the most valuable
Meta’s speeding up the ‘Mad Men to Math Men’ pipeline Read More »
Hims & Hers, the telehealth and wellness company, has hired a veteran of the autonomous vehicle industry as its next chief technology officer. The move, according to Hims & Hers co-founder and CEO, Andrew Dudum, was intentional. Hims & Hers on Thursday said its next CTO would be Mo Elshenawy, the former president and CTO
Why Hims & Hers turned to the autonomous vehicle industry to find an AI-savvy CTO Read More »
OpenAI has met with officials from the U.S. Food and Drug Administration to discuss the agency’s use of AI to speed up drug evaluations, Wired reported on Wednesday. According to the report, OpenAI and the FDA have discussed a project called cderGPT, which seems to be an AI tool for the Center for Drug Evaluation
OpenAI and the FDA are reportedly discussing AI for drug evaluations Read More »
FutureHouse, an Eric Schmidt-backed nonprofit that aims to build an “AI scientist” within the next decade, has released a new tool that it claims can help support “data-driven discovery” in biology. The new tool comes just a week after FutureHouse launched its API and platform. The tool, called Finch, takes in biology data (primarily in the
FutureHouse previews an AI tool for ‘data-driven’ biology discovery Read More »
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat Friedman, Daniel Gross, and Khosla Ventures also invested, as did returning backers Founders Fund, Dimension Capital, Elad Gil, Garry Tan, Patrick
NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has raised a $130 million Series B led by Kleiner Perkins. New investors Nat Friedman, Daniel Gross, and Khosla Ventures also invested, as did returning backers Founders Fund, Dimension Capital, Elad Gil, Garry Tan, Patrick
With long waiting lists and rising costs in overburdened healthcare systems, many people are turning to AI-powered chatbots like ChatGPT for medical self-diagnosis. About 1 in 6 American adults already use chatbots for health advice at least monthly, according to one recent survey. But placing too much trust in chatbots’ outputs can be risky, in
People struggle to get useful health advice from chatbots, study finds Read More »
